HCRAX Rating, Research - Invesco Health Sciences A

Invesco Health Sciences A (hcrax)

Last Updated by WikiWealth | Update This Page Now

►Summary | Add New Mutual Fund | Feedback

Short Term Rating Stock Ratings Help

Asset Allocation (% of Port)

US Stocks
Non-US Stocks

Geographic Allocation (% of Port)

North America
South America
Australia + Pacific Islands
Long Term Rating Stock Ratings Help


SWOT Statistics

Strengths + Opportunities = 56

Threats + Weaknesses = 35

When strengths & opportunities substantially exceed threats & weaknesses an investment in the hcrax mutual fund has great long term potential.

Fund Management Team

Fund Description Update

Invesco Health Sciences A (HCRAX) Description: HCRAX is a mutual fund, which is an investment that owns a basket of assets. The HCRAX mutual fund was provided by Invesco and this investment vehicle derives the majority of its value from equity holdings (stocks). Invescos mutual fund has a short management tenure and is in the average fund size classification. HCRAXs minimum initial investment amount is $1000 while the IRA minimum is $250. HCRAXs expense ratio is roughly 2%. The latest HCRAXs front end load was 6% and the back end load was 0%. The Invesco Health Sciences A (HCRAX) mutual fund falls under the health category. HCRAX focuses its investments in USA and HCRAX is focused on the health industry or fund sector. The Invesco Health Sciences A (HCRAX) mutual fund is not a leveraged fund and it does not have inverse fund properties. An investor can find HCRAXs top holdings, fundamental analysis, ratings, and fund risk (volatility) on the left side of the screen. The right side of HCRAXs research report features technical analysis and long term investment potential.

Portfolio Strategy Update

This investment vehicle seeks capital appreciation. The fund normally invests at least 80% of assets in common stocks (see stock research) (including depositary receipts) of health science companies throughout the world. It may invest up to 50% of net assets in foreign securities, including emerging-market securities. The fund may also use derivative instruments.

Management Analysis Update

Performance Analysis Update